We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$16.4B
AUM Growth
+$49.9M
(+0.3%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
43.8%
Holding
1,532
New
77
Increased
144
Reduced
521
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coty
COTY
|
+$139M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$38M |
| 3 |
GCP
GCP Applied Technologies Inc.
GCP
|
+$34.7M |
| 4 |
Sonida Senior Living
SNDA
|
+$25.5M |
| 5 |
Theravance Biopharma
TBPH
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$68M |
| 2 |
ConocoPhillips
COP
|
+$44.3M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$35.7M |
| 4 |
Zimmer Biomet
ZBH
|
+$33.7M |
| 5 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.47% |
| 2 | Healthcare | 12.64% |
| 3 | Industrials | 9.32% |
| 4 | Technology | 8.7% |
| 5 | Consumer Staples | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Warner Bros
WBD
$65.9B
| $12.8M | 0.08% |
468,576
-7,088
| -1% | -$192K |
|
152
S&P Global
SPGI
$126B
| $12.7M | 0.08% |
118,023
+9,355
| +9% | +$1.12M |
|
153
AbbVie
ABBV
$458B
| $12.5M | 0.08% |
199,626
-956
| -0.5% | -$58.4K |
|
|
DBVT
154
DBV Technologies
DBVT
$804M
| $12M | 0.07% |
34,227
+2,885
| +9% | +$1.04M |
|
155
Citizens Financial Group
CFG
$30.6B
| $12M | 0.07% |
335,447
-6,800
| -2% | -$206K |
|
156
Northern Trust
NTRS
$22.2B
| $11.9M | 0.07% |
133,412
-4,816
| -3% | -$383K |
|
157
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $11.7M | 0.07% |
52,408
+9,004
| +21% | +$1.97M |
|
158
Commercial Metals
CMC
$7.64B
| $11.4M | 0.07% |
525,355
-12,502
| -2% | -$245K |
|
|
CHK
159
DELISTED
Chesapeake Energy Corporation
CHK
| $11.1M | 0.07% |
7,941
+2,131
| +37% | +$2.79M |
|
160
Avis
CAR
$5.7B
| $11.1M | 0.07% |
301,590
-6,470
| -2% | -$234K |
|
161
PNC Financial Services
PNC
$101B
| $11M | 0.07% |
93,841
-885
| -0.9% | -$92K |
|
|
STAY
162
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $11M | 0.07% |
+678,500
| New | +$10.2M |
|
|
GXP
163
DELISTED
Great Plains Energy Incorporated
GXP
| $10.9M | 0.07% |
398,643
-10,340
| -3% | -$283K |
|
164
Akebia Therapeutics
AKBA
$327M
| $10.8M | 0.07% |
1,038,500
-666,800
| -39% | -$5.74M |
|
|
PMBC
165
DELISTED
Pacific Mercantile Bancorp
PMBC
| $10.8M | 0.07% |
1,475,294
-128,580
| -8% | -$865K |
|
166
Essential Utilities
WTRG
$11.2B
| $10.7M | 0.07% |
355,861
-8,612
| -2% | -$257K |
|
|
WBA
167
DELISTED
Walgreens Boots Alliance
WBA
| $10.7M | 0.06% |
128,921
-2,909
| -2% | -$241K |
|
|
TCF
168
DELISTED
TCF Financial Corporation Common Stock
TCF
| $10.6M | 0.06% |
195,321
-5,895
| -3% | -$287K |
|
169
McCormick & Company Non-Voting
MKC
$13.7B
| $10.3M | 0.06% |
221,706
-1,996
| -0.9% | -$93.1K |
|
|
SAVE
170
DELISTED
Spirit Airlines, Inc.
SAVE
| $10.2M | 0.06% |
+176,875
| New | +$9.12M |
|
|
AGFS
171
DELISTED
AgroFresh Solutions Inc
AGFS
| $10.1M | 0.06% |
3,825,993
+641,865
| +20% | +$2.37M |
|
|
SCHW
172
Charles Schwab
SCHW
$177B
| $9.97M | 0.06% |
252,515
-999,750
| -80% | -$35.7M |
|
173
Liberty Broadband Class A
LBRDA
$4.08B
| $9.93M | 0.06% |
137,006
-376
| -0.3% | -$25.8K |
|
174
Intel
INTC
$488B
| $9.8M | 0.06% |
270,294
-52,364
| -16% | -$1.87M |
|
175
Eli Lilly
LLY
$1.07T
| $9.33M | 0.06% |
126,863
+2,943
| +2% | +$219K |
|
Similar funds
SAM
First Manhattan's Q4 2016 Portfolio in Review
As of Q4 2016, First Manhattan held 1,532 positions worth $16.4B, up 0.3% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q4 2016 filing shows 77 new, 144 increased, 521 reduced and 96 closed positions. Its largest new stake was Coty: 6,723,666 shares worth $123M. The largest sale was Allergan plc, an estimated $68M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q4 2016 buy was Coty: 6,723,666 shares worth $123M.
- First Manhattan added most to Teva Pharmaceuticals in Q4 2016, an estimated $38M increase.
- First Manhattan's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $68M.
- First Manhattan fully exited Starz - Series A in Q4 2016, selling an estimated $2.9M.
- First Manhattan's ten largest holdings make up 44% of its $16.4B portfolio in Q4 2016.
- First Manhattan opened 77 new positions and closed 96 in Q4 2016.
- First Manhattan's portfolio value rose 0.3% quarter-over-quarter to $16.4B.
Based on First Manhattan's 13F filing for Q4 2016, filed 25 Jan 2017.